{"id":"https://openalex.org/W2076421330","doi":"https://doi.org/10.4161/hv.1.1.1335","title":"A DNA-Based Vaccine for the Prevention of Human Cytomegalovirus-Associated Diseases","display_name":"A DNA-Based Vaccine for the Prevention of Human Cytomegalovirus-Associated Diseases","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2076421330","doi":"https://doi.org/10.4161/hv.1.1.1335","mag":"2076421330","pmid":"https://pubmed.ncbi.nlm.nih.gov/17038834"},"language":"en","primary_location":{"id":"doi:10.4161/hv.1.1.1335","doi":"https://doi.org/10.4161/hv.1.1.1335","is_oa":true,"landing_page_url":"https://doi.org/10.4161/hv.1.1.1335","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/hv.1.1.1335?needAccess=true&role=button","source":{"id":"https://openalex.org/S91403448","display_name":"Human Vaccines","issn_l":"1554-8600","issn":["1554-8600","1554-8619"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.4161/hv.1.1.1335?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013367239","display_name":"Cheryl L. Selinsky","orcid":"https://orcid.org/0000-0002-8792-055X","observed_orcids":["https://orcid.org/0000-0002-8792-055X"]},"institutions":[{"id":"https://openalex.org/I4210100637","display_name":"Vical (United States)","ror":"https://ror.org/00w230w05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100637"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Selinsky","raw_affiliation_strings":["Vical Incorporated, San Diego, California, USA. CSelinsky@vical.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vical Incorporated, San Diego, California, USA. CSelinsky@vical.com","institution_ids":["https://openalex.org/I4210100637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059355135","display_name":"Catherine J. Luke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100637","display_name":"Vical (United States)","ror":"https://ror.org/00w230w05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100637"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Luke","raw_affiliation_strings":["Vical Incorporated ; San Diego , California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vical Incorporated ; San Diego , California USA","institution_ids":["https://openalex.org/I4210100637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024791044","display_name":"Mary Kopke Wloch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100637","display_name":"Vical (United States)","ror":"https://ror.org/00w230w05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100637"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Wloch","raw_affiliation_strings":["Vical Incorporated ; San Diego , California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vical Incorporated ; San Diego , California USA","institution_ids":["https://openalex.org/I4210100637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003331131","display_name":"Andrew J Geall","orcid":"https://orcid.org/0000-0001-9930-3316","observed_orcids":["https://orcid.org/0000-0001-9930-3316"]},"institutions":[{"id":"https://openalex.org/I4210100637","display_name":"Vical (United States)","ror":"https://ror.org/00w230w05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100637"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Geall","raw_affiliation_strings":["Vical Incorporated ; San Diego , California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vical Incorporated ; San Diego , California USA","institution_ids":["https://openalex.org/I4210100637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075291658","display_name":"Gary Hermanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100637","display_name":"Vical (United States)","ror":"https://ror.org/00w230w05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100637"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Hermanson","raw_affiliation_strings":["Vical Incorporated ; San Diego , California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vical Incorporated ; San Diego , California USA","institution_ids":["https://openalex.org/I4210100637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011187406","display_name":"David C. Kaslow","orcid":"https://orcid.org/0000-0003-3557-383X","observed_orcids":["https://orcid.org/0000-0003-3557-383X"]},"institutions":[{"id":"https://openalex.org/I4210100637","display_name":"Vical (United States)","ror":"https://ror.org/00w230w05","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100637"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Kaslow","raw_affiliation_strings":["Vical Incorporated ; San Diego , California USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vical Incorporated ; San Diego , California USA","institution_ids":["https://openalex.org/I4210100637"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012821937","display_name":"Thomas G. Evans","orcid":"https://orcid.org/0000-0001-9917-3363","observed_orcids":["https://orcid.org/0000-0001-9917-3363"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Evans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.6901,"has_fulltext":true,"cited_by_count":75,"citation_normalized_percentile":{"value":0.9698992,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"1","issue":"1","first_page":"16","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-cytomegalovirus","display_name":"human cytomegalovirus","score":0.9810000061988831},{"id":"https://openalex.org/keywords/plasmid-dna-vaccination","display_name":"plasmid DNA immunization","score":0.8550000190734863},{"id":"https://openalex.org/keywords/bivalent-vaccine","display_name":"bivalent vaccine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.4790000021457672},{"id":"https://openalex.org/keywords/transplant-recipients","display_name":"transplant recipients","score":0.8579999804496765},{"id":"https://openalex.org/keywords/antibody-response","display_name":"antibody response","score":0.7639999985694885},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.8640000224113464}],"concepts":[{"id":"https://openalex.org/C2779820661","wikidata":"https://www.wikidata.org/wiki/Q6929","display_name":"Human cytomegalovirus","level":3,"score":0.7489516735076904},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7016021013259888},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6955826282501221},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5896589159965515},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5711427927017212},{"id":"https://openalex.org/C167508917","wikidata":"https://www.wikidata.org/wiki/Q578537","display_name":"DNA vaccination","level":4,"score":0.5632092952728271},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4902504086494446},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4803934693336487},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4791121482849121},{"id":"https://openalex.org/C2776620830","wikidata":"https://www.wikidata.org/wiki/Q4919211","display_name":"Bivalent (engine)","level":3,"score":0.44559502601623535},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4284975230693817},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38615405559539795},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3337421417236328},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1027350127696991},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.08981433510780334},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C544153396","wikidata":"https://www.wikidata.org/wiki/Q11426","display_name":"Metal","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004279","descriptor_name":"DNA, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005814","descriptor_name":"Genes, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013501","descriptor_name":"Surface-Active Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D015967","descriptor_name":"Gene Expression Regulation, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D019444","descriptor_name":"Vaccines, DNA","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019444","descriptor_name":"Vaccines, DNA","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020442","descriptor_name":"Poloxamer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022482","descriptor_name":"Cytomegalovirus Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D022482","descriptor_name":"Cytomegalovirus Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4161/hv.1.1.1335","doi":"https://doi.org/10.4161/hv.1.1.1335","is_oa":true,"landing_page_url":"https://doi.org/10.4161/hv.1.1.1335","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/hv.1.1.1335?needAccess=true&role=button","source":{"id":"https://openalex.org/S91403448","display_name":"Human Vaccines","issn_l":"1554-8600","issn":["1554-8600","1554-8619"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines","raw_type":"journal-article"},{"id":"pmid:17038834","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17038834","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human vaccines","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/hv.1.1.1335","doi":"https://doi.org/10.4161/hv.1.1.1335","is_oa":true,"landing_page_url":"https://doi.org/10.4161/hv.1.1.1335","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/hv.1.1.1335?needAccess=true&role=button","source":{"id":"https://openalex.org/S91403448","display_name":"Human Vaccines","issn_l":"1554-8600","issn":["1554-8600","1554-8619"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2076421330.pdf","grobid_xml":"https://content.openalex.org/works/W2076421330.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2056683115","https://openalex.org/W2065120197","https://openalex.org/W2002480041","https://openalex.org/W155120875","https://openalex.org/W2384292551","https://openalex.org/W2060619545","https://openalex.org/W1976166974","https://openalex.org/W2469521588","https://openalex.org/W2035892143","https://openalex.org/W1593830332"],"abstract_inverted_index":{"Multiple":[0],"lines":[1],"of":[2,84,103,109,219],"evidence":[3],"indicate":[4],"that":[5,29,67,75],"in":[6,31,92,114,140,179,186,192,198,211],"the":[7,47,54,61,77,93,167,176,184,196,214],"transplant":[8,94],"population":[9],"human":[10,230],"cytomegalovirus":[11],"(HCMV)":[12],"infection":[13],"and":[14,22,53,107,135,147,181,204,208,221],"its":[15],"associated":[16],"diseases":[17,91],"are":[18],"controlled":[19],"by":[20],"humoral":[21],"cellular":[23,56],"immune":[24,57,169],"responses":[25,79,150,170,190],"similar":[26],"to":[27,43,46,60,80,122,151,172,229],"those":[28,173],"arise":[30],"asymptomatic,":[32],"healthy":[33],"individuals":[34],"during":[35],"a":[36,159,205],"naturally-acquired":[37],"infection.":[38],"The":[39],"dominant":[40,55],"antibody":[41,146],"response":[42,58],"HCMV":[44,85,216],"is":[45,59],"major":[48,81],"surface":[49],"glycoprotein":[50],"B":[51],"(gB)":[52],"tegument":[62],"phosphoprotein":[63],"(pp65).":[64],"We":[65,96],"propose":[66],"an":[68],"immunotherapeutic":[69,100],"plasmid":[70],"DNA":[71],"(pDNA)":[72],"vaccination":[73,123,132],"approach":[74],"induces":[76],"requisite":[78],"immunological":[82],"targets":[83],"may":[86],"provide":[87],"relief":[88],"from":[89],"HCMV-associated":[90],"setting.":[95],"have":[97],"developed":[98],"gene-based":[99],"products":[101],"consisting":[102,218],"pDNAs":[104,117,137,197,223],"encoding":[105],"gB":[106,126,134,220],"pp65":[108,128,136,222],"HCMV.":[110],"When":[111],"tested":[112],"individually":[113],"mice,":[115],"both":[116],"were":[118],"highly":[119],"immunogenic.":[120],"Relative":[121],"with":[124,133,158,175,195,225],"either":[125],"or":[127],"pDNA":[129],"delivered":[130,138,224],"alone,":[131],"together":[139],"phosphate-buffered":[141],"saline":[142],"(PBS)":[143],"elicited":[144],"reduced":[145],"T":[148,188],"cell":[149,189],"each":[152],"antigen.":[153],"Formulating":[154],"this":[155],"bivalent":[156,177,215],"vaccine":[157,178,217],"poloxamer-based":[160],"delivery":[161],"system":[162],"(VF-P1205-02A),":[163],"however,":[164],"significantly":[165],"increased":[166],"antigen-specific":[168],"relative":[171],"induced":[174],"PBS,":[180],"completely":[182],"abrogated":[183],"decrease":[185],"pp65-specific":[187],"observed":[191],"mice":[193],"covaccinated":[194],"PBS.":[199],"Based":[200],"on":[201],"these":[202],"data,":[203],"favorable":[206],"safety":[207],"toxicity":[209],"profile":[210],"preclinical":[212],"studies,":[213],"VF-P1205-02A":[226],"has":[227],"advanced":[228],"clinical":[231],"trials.":[232]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}